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Background: Data derived from prospective randomized clinical trials suggest differential comparative benefit between
carotid angioplasty and stent (CAS) placement and carotid endarterectomy (CEA) in various age strata. We sought to
investigate the impact of age on outcomes of CAS and CEA in general practice.
Methods:We analyzed the data from the Nationwide Inpatient Sample (NIS), which is representative of all admissions in
the United States from 2005 to 2008. The primary end point was occurrence of stroke, cardiac complications, or death
during the postprocedural period. Outcomes of interest were compared between patients aged>70 years and<70 years,
undergoing CEA and CAS. Multivariate logistic regression was performed to determine the effect of age on occurrence
of postoperative stroke, cardiac complications, or death. Covariates included in the logistic regression were patient’s age,
gender, comorbid conditions, including hypertension, diabetes mellitus (DM), chronic lung disease, coronary artery
disease (CAD), congestive heart failure (CHF), and renal failure; symptom status (symptomatic vs asymptomatic status),
and hospital characteristics.
Results: Of the total 495,331 estimated patients who received treatment for CAD during the study period, 88%
underwent CEA and the remaining 12% underwent CAS. Of the total procedures, 41% of the procedures were performed
in patients aged <70 years compared to the remaining 59% that were performed among patients aged >70 years. For
patients undergoing CAS, age>70 years was an important predictor of postoperative stroke (P .0025; odds ratio [OR],
1.7; 95% confidence interval [CI], 1.2-2.5) and cardiac complications postprocedure (P  .045; OR, 1.3; 95% CI,
1.0-1.6). For patients undergoing CEA, age >70 years was associated with higher cardiac complications (P < .001; OR,
1.5; 95% CI, 1.3-1.7) and higher postoperative mortality risk (P  .0008; OR, 1.4; 95% CI, 1.1-1.8) compared to
patients aged <70 years. The increased risk of composite end point (postoperative stroke/cardiac complications/
mortality) among patients aged>70 years was a significant factor for patients undergoing either CAS or CEA (OR of 1.3
for both procedures).
Conclusion:Our analysis suggests that most CAS and CEAs are performed in patients aged>70 years in general practice,
and higher rates of postoperative complications are observed among these patients regardless of procedure choice.
(J Vasc Surg 2012;55:72-8.)
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tExtracranial atherosclerotic carotid disease accounts for
up to 15% to 20% of all ischemic strokes.1,2 According to
the most recent American Heart Association/American
Stroke Association guidelines about management of pa-
tients with extracranial carotid stenosis, both carotid angio-
plasty and stent (CAS) placement and carotid endarterec-
tomy (CEA) are reasonable options for carotid disease
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72evascularization. These recommendations also include a
tatement emphasizing the importance of age in patient
election. According to these guidelines, it is reasonable to
hoose CEA over CAS when revascularization is indicated
n older patients; particularly when vascular anatomy is
nfavorable for the endovascular approach.1 The age cut-
ff, however, is not mentioned in these guidelines.
In the recently published Carotid Revascularization
ndarterectomy versus Stenting Trial (CREST) trial, a
rossover was observed at an age of approximately 70
ears where CAS tended to show greater efficacy at
ounger ages, and CEA at older ages.3 However, the
esults of carotid revascularization in general practice
etting vary considerably and are suboptimal in several
ettings.4,5 The differential outcomes in general practice
ave been attributed to the difference in patient popula-
ion, variable experience of operators, failure to measure
nd diagnose quality/performance gaps, and implement
uality improvement interventions in a timely fashion.
herefore, the age-related difference in outcomes iden-
ified in clinical trials may be augmented or blunted in
he general practice setting.
Our objective was to identify if such suggested differ-
ntial results in age strata are also observed in general
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Volume 55, Number 1 Khatri et al 73practice at the national level among patients undergoing
CEA and CAS.
METHODS
Study sample. In order to evaluate the characteristics
and outcomes for patients undergoing CEA or CAS in the
United States, we used the Nationwide Inpatient Sample
(NIS) for the calendar year, from 2005 to 2008. The NIS is
the largest database of its kind and includes all-payer dis-
charge information from a national survey of nonfederal
hospitals in the United States. The NIS provides a weight-
ing strategy in order to draw estimates at the national level
based on a 20% annual survey of hospitals. The statistical
analyses are performed based on these weighted numbers
and, therefore, the data provided in the Results section are
national estimates. A complete overview and description of
the NIS is available at http://www.hcup-us.ahrq.gov.
Identification of patients and procedures. We used
International Classification of Disease, 9th Revision, Clin-
ical Modification (ICD-9-CM) codes similar to previously
published reports on carotid revascularization comparing
CEA and CAS at the national level using NIS data for the
year 2005.6 Diagnostic code fields were screened for ICD-
9-CM code for either CAS (00.63) or CEA (38.12) with
the corresponding diagnostic code for carotid artery steno-
sis with (433.11) or without (433.10) stroke. We used the
criterion which has been used previously6 to differentiate
the symptomatic from asymptomatic patients with carotid
stenosis. If a patient’s discharge diagnosis (diagnostic fields
1-15) was “carotid artery stenosis without mention of
stroke” with no accompanying secondary diagnoses for
transient ischemic attack (TIA), they were classified as
“asymptomatic.” If a patient’s discharge diagnosis was ei-
ther “carotid artery stenosis with stroke” or, if there was no
mention of stroke, but a secondary diagnosis code included
that for TIA, patients were classified as “symptomatic.” A
patient was excluded from the final dataset if he or she had
procedural codes listed for both CAS and CEA (1% of
total) during the index admission in the interest of keeping
the cohorts as homogenous as possible to facilitate compar-
ison between the two procedure types.
The variables abstracted were patients’ age, gender,
race/ethnicity, comorbidities (congestive heart failure
[CHF], coronary artery disease [CAD], diabetes mellitus
[DM], hypertension, peripheral vascular disease, renal fail-
ure, obesity, and chronic lung disease), procedures per-
formed (CEA or CAS), and hospital characteristics in which
they were treated (rural, urban nonteaching, urban teach-
ing hospitals) and discharge disposition. The NIS defines
an urban hospital as one located in a metropolitan statistical
area and a teaching hospital as one with American Medical
Association-approved residency program and either mem-
bership in the Council of Teaching Hospitals or a ratio of
full-time equivalent interns and residents to beds of 0.25 or
higher. The NIS does not divide rural hospitals into teach-
ing or nonteaching because of the small number of teach-
ing hospitals in rural areas. aThe primary outcome measures for this analysis were
rocedure-related complications, including postoperative
eurological complications, cerebral infarction or hemor-
hage (ICD-9-CM codes 997.00-997.09) and postopera-
ive cardiac complications (ICD-9-CM code 997.1). A
atient undergoing CAS or CEA that had any of these
odes under one of their secondary ICD-9-CM diagnostic
odes (up to 15), was classified as having had an iatrogenic
troke or cardiac complications. Secondary outcome mea-
ures included discharge disposition. Discharge disposition
or the purpose of analysis was condensed to a dichotomous
ariable, home vs other destinations (rehabilitation facility,
killed nursing facility, nursing home, and death).
Statistical analysis. We sought to investigate the
mpact of age on outcomes associated with CAS and
EA in NIS. The primary end point was comparison of
ostoperative stroke, cardiac complications, and in-
ospital death during the postprocedural period between
atients aged 70 years and those aged 70 years for
AS and CEA separately. We used a multivariate model,
djusting for demographic and hospital characteristics,
nd comorbid conditions between 70 years and those
ged 70 years. In addition, we also compared discharge
estination of home as a surrogate of good outcome. To
scertain the outcome variables in different age groups, we
lso evaluated the age factor by every decade increase from
he age of 50 years. We also compared CEA and CAS in
nivariate analysis in both age groups,70 years and those
ged 70 years.
We used the SAS 9.1 software (SAS Institute, Cary,
C) to convert raw counts generated from the NIS data-
ase into weighted counts that we used to generate national
stimates. The statistical analysis was performed based on
hese weighted numbers and incorporated the complex
ampling of NIS, following Healthcare Cost and Utiliza-
ion Project (HCUP) recommendations.7 We used the 2
est for categorical data and analysis of variance for contin-
ous data with a P .05 considered statistically significant.
utcomes of interest were compared between CEA and
AS in patients aged 70 years and patients aged 70
ears. Multivariate logistic regression was performed to
etermine the effect of age on postoperative stroke, cardiac
omplications, or death after adjusting for potential con-
ounders. Potential confounders included in the logistic
egression were gender, comorbid conditions (hyperten-
ion, DM, chronic lung disease, CAD, CHF, and renal
ailure), carotid stenosis symptom status (symptomatic vs
symptomatic), and hospital characteristics (teaching status
nd bed size).
ESULTS
Of the total 495,331 estimated patients who under-
ent CEA or CAS during the study period from 2005 to
008 in the United States; 88% underwent CEA and the
emaining 12% underwent CAS. The vast majority of pa-
ients (approximately 93% in the CAS group and 96% in the
EA group) were asymptomatic by the definition used for
scertaining symptomatic status.
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tients aged 70 years and 59% were performed among
patients aged 70 years. Table I provides the univariate
comparison of variables between patients who underwent
CAS or CEA. Among patients undergoing CAS, postoper-
ative mortality was higher but not statistically different in
patients aged 70 years compared with 70 years signifi-
cant (0.7% vs 0.5%; P .1171). Postoperative stroke (1.9%
vs 1.3%) and cardiac complication (2.4% vs 1.9%) rates were
higher in patients aged 70 years compared with those
aged 70 years. The rate of discharge to home was lower
among patients aged70 years undergoingCAS compared
with those in70 years. Among patients undergoing CEA,
the postoperative stroke rate was not different in patients
aged 70 years (0.95%) compared to 70 years (1.0%).
Cardiac complication (2.2% vs 1.3%) and postoperative
mortality (0.4% vs 0.2%) rates were higher in patients aged
70 years compared with those in 70 years. The rate of
discharge to home was lower among patients aged 70
Table I. Patient characteristics, hospital characteristics, an
practice (NIS 2005 to 2008)
Patients undergoing C
Age 70 years Age 70 year
Overall number (%) 24,063 33,563
Gender
Women 9710 (40.3) 13,165 (39.2)
Age (mean) 61.1 77.8
Race/ethnicitya
White 15,422 (85.1) 22,897 (87.3)
African American 764 (4.2) 896 (3.4)
Hispanic 967 (5.3) 1052 (4.0)
Other 954 (5.2) 1370 (5.2)
Comorbid conditions
Hypertension 17,086 (71.0) 24,835 (73.9)
Diabetes mellitus 7760 (32.2) 9256 (27.5)
Coronary artery disease 12,313 (51.2) 18,809 (56.1)
Chronic lung disease 4851 (20.1) 6474 (19.2)
Congestive heart failure 2039 (8.4) 3823 (11.4)
Renal failure 1530 (6.3) 2943 (8.7)
Hospital bed size
Small 2047 (8.5) 3475 (10.3)
Medium 4491 (18.6) 6277 (18.7)
Large 17,525 (72.8) 23,811 (70.9)
Hospital location and
teaching status
Rural 773 (3.2) 838 (2.5)
Urban nonteaching 8483 (35.3) 13,929 (41.5)
Urban teaching 14,808 (61.5) 18,795 (56.0)
Discharge disposition
Home 22,372 (92.9) 29,843 (88.9)
Other destinations 1691 (7.1) 3720 (11.1)
In-hospital complications
Postoperative mortality 184 (0.7) 170 (0.5)
Postoperative stroke 326 (1.3) 663 (1.9)
Postoperative cardiac
complications
468 (1.9) 835 (2.4)
Composite end point 900 (3.7) 1513 (4.5)
CAS, Carotid artery stenting; CEA, carotid endarterectomy; NIS, Nationw
aRace is not uniformly reported among all states.years undergoing CEA. sAfter adjustment for potential confounders, the odds
f cardiac complications were significantly higher among
atients aged 70 years undergoing CAS (odds ratio
OR], 1.3) and in those undergoing CEA (OR, 1.5;
able II). The odds of postoperative stroke was signifi-
antly higher among patients aged 70 years undergo-
ng CAS (OR, 1.7) but not in those undergoing CEA.
he odds of postprocedural death was significantly
igher among patients aged 70 years undergoing CEA
OR, 1.4) but not in those undergoing CAS. The odds of
ostoperative stroke or cardiac complications and com-
osite end point (postoperative stroke, cardiac compli-
ations, and/or death) among patients aged 70 years
as a significant factor for patients undergoing either
AS or CEA with similar effect (OR of 1.3 for both
rocedures). Table II provides the multivariate compar-
son of patients aged 70 years (compared with those
ged 70 years) who underwent CAS or CEA.
We plotted the rate of various outcomes in different age
tcome in patients undergoing CAS or CEA in general
Patients undergoing CEA
P value Age 70 years Age 70 years P value
180,827 256,878
.2366 74,706 (41.3) 110,540 (43.0) .0001
61.9 77.5
.0067 118,461 (88.9) 176,168 (90.3) .0001
4962 (3.7) 5547 (2.8)
5182 (3.8) 7145 (3.6)
4536 (3.4) 6121 (3.1)
.0007 139,455 (77.1) 203,924 (79.3) .0001
.0001 58,097 (28.6) 73,511 (32.1) .0001
.0001 78,235 (43.2) 121,317 (47.2) .0001
.2848 41,446 (22.9) 53,742 (20.9) .0001
.0001 8142 (7.2) 18,671 (4.5) .0001
.0001 7884 (4.3) 17,475 (6.8) .0001
.1767 16,331 (9.0) 24,619 (9.5) .1435
40,552 (22.4) 58,754 (22.8)
123,893 (68.5) 173,479 (67.5)
.0001 16,783 (9.2) 24,327 (9.4) .0001
86,906 (48.1) 129,527 (50.4)
77,087 (42.6) 102,999 (40.1)
.0001 13,975 (92.2) 222,695 (86.6) .0001
166,852 (7.7) 34,183 (13.3)
.1171 529 (0.2) 1227 (0.4) .0001
.0158 1846 (1.0) 2443 (0.95) .2988
.0481 2494 (1.3) 5774 (2.2) .0001
.0538 4515 (2.4) 8768 (3.4) .0001
atient Sample.d ou
AS
strata, (by decades) (Fig 1) to identify patterns of change in
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crease in various stratas. We found that the risk of cardiac
complications and mortality, but not stroke, among pa-
tients undergoing CEA gradually increased with age. In
contrast, the risk of stroke but not cardiac complications,
among patients undergoing CAS (Fig 2) gradually in-
creased with age.
A direct comparison of CEA and CAS demonstrated
that in patients 70 years, the unadjusted rate of postop-
erative stroke and composite end point were statistically
favoring CEA. Similarly for patients70 years, unadjusted
in-hospital mortality and composite end point were again
statistically favoring CEA (Table III).
DISCUSSION
Our analysis demonstrated that most CASs and
CEAs are performed in patients aged 70 years in gen-
eral practice and higher rates of postoperative complica-
tions are observed among these patients regardless of
procedure choice. The ideal method to address the issue
Table II. The adjusted odds of various outcome measures
years) among patients undergoing CAS or CEA in general
Patients u
OR (95% CI)
Postoperative stroke 1.7 (1.2-2.5)
Postoperative cardiac complications 1.3 (1.0-1.6)
Postoperative mortality 0.8 (0.5-1.4)
Stroke/cardiac complications 1.4 (1.1-1.7)
Composite end point 1.3 (1.1-1.7)
CAS, Carotid artery stenting; CEA, carotid endarterectomy; CI, confidence
The multivariate model adjusts for gender, hypertension, diabetes mellitus, c
symptomatic carotid stenosis, teaching status of hospital, and hospital bed s
Fig 1. Rate of study end points among various age stra
placement.would be to compare outcomes between CAS and CAS rmong patients in the two age strata matched for prog-
ostic characteristics. However, such a matched compar-
son is not possible because the characteristics of patients
ndergoing CAS and CEA are different in the “real-
orld setting.”8-11 Therefore, we used an alternative
pproach to determine the increase in composite end
oint for both CAS and CEA in the two age strata. We
ound that the increased odds of composite end point
ere similar for both CAS and CEA (OR of 1.3). The
esults suggest that in the general practice setting, the
ifferential benefit of CEA over CAS among patients
ged 70 years is blunted because of high rate of post-
perative cardiac complications and mortality in patients
ndergoing CEA. The other finding was a higher rate of
ostoperative stroke among patients aged 70 years
ndergoing CAS but not in those undergoing CEA
Table II).
The age of the patient is an important consideration
efore planning a carotid revascularization procedure. Oc-
ogenarians were excluded from most of the prospective
atients aged 70 years (compared with those aged 70
tice (NIS 2005 to 2008)
oing CAS Patients undergoing CEA
P value OR (95% CI) P value
.0025 0.9 (0.8-1.1) .1928
.045 1.5 (1.3-1.7) .0001
.6433 1.4 (1.1-1.8) .0008
.0019 1.2 (1.2-1.4) .0001
.0035 1.3 (1.2-1.4) .0001
val; NIS, Nationwide Inpatient Sample; OR, odds ratio.
ry artery disease, chronic lung disease, renal failure, congestive heart failure,
ong patients undergoing carotid angioplasty and stentin p
prac
nderg
interta amandomized multi-institution studies evaluating CEA, in-
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tomy Trial (NASCET)12 and Asymptomatic Carotid Ath-
erosclerosis Study (ACAS).13 Themean age of the included
patients in these trials of CEA has been less than 70 years.14
In the NASCET, the greatest benefit of CEA compared
with medical management was observed in older patients.
However, several studies have suggested that the perioper-
ative complications are higher with CEA among patients
over the age of 75 in general practice.15 Therefore, CAS
was initially introduced as a less invasive procedure for
elderly patients with multiple medical comorbidities. The
Stenting and Angioplasty with Protection in Patients at
High Risk for Endarterectomy (SAPPHIRE) trial, in which
CAS had superior outcomes to CEA in medical high-risk
patients, included approximately 20% octogenarians in
each treatment arm, however, the benefit was mainly be-
cause of a lower rate of myocardial infarction in the CAS
group.16 In contrast to the SAPPHIRE trial, in standard-
risk patients, a meta-analysis demonstrated increased risk of
stroke in octogenarians undergoingCAS compared to CEA
with CEA being a safer alternative.17 Similarly, the Carotid
Fig 2. Rate of study end points among various age s
Table III. Univariate analysis of postoperative outcomes b
Age 70
CAS CE
Overall number (%) 24,063 180,
In-hospital complications
In-hospital mortality 184 (0.76) 529 (
Postoperative stroke 326 (1.35) 1846 (
Postoperative cardiac complications 468 (1.94) 2494 (
Composite end point 900 (3.74) 4515 (
CAS, Carotid artery stenting; CEA, carotid endarterectomy; NIS, NationwRX Acculink/Accunet Post-Approval Trial to Uncover snanticipated or Rare Events (CAPTURE) study—a mul-
icenter postmarketing registry also found a higher event
ate in octogenarians compared with the younger cohort
7% vs 4%).18,19 Despite important implications of a poten-
ial impact of age on outcomes of CAS and CEA, little
nformation is available from general practice settings.
The mismatch between results derived from general
ractice and those from randomized trials has been identi-
ed in previous studies of carotid revascularization. An
nalysis of 113,300 patients on Medicare undergoing CEA
eported that patients’ perioperative mortality after CEA
as substantially higher than that reported in the trials,
ven in those institutions that participated in the random-
zed studies.11 An audit of CEA practices in 1997 to 1998
n six hospitals9 demonstrated that 15% of the CEAs were
erformed for inappropriate indications; the complication
ate in asymptomatic patients with high comorbidity was
%, and those undergoing CEAwith coronary artery bypass
rafting was 10%, both rates incompatible with clinical
enefit of the procedure. The New York Carotid Artery
urgery Study (NYCAS) was a population-based cohort
among patients undergoing carotid endarterectomy.
en CEA and CAS by age cohort (NIS 2005 to 2008)
Age 70 years
P value CAS CEA P value
33,549 256,826
) .0008 170 (0.50) 1227 (0.47) .7458
) .0897 663 (1.97) 2443 (0.95) .0001
) .0213 835 (2.48) 5774 (2.24) .3087
) .0002 1513 (4.5) 8768 (3.4) .0004
atient Sample; OR, odds ratio.etwe
years
A
827
0.29
1.02
1.37
2.49tudy of all CEAs performed on elderly patients from
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Among the 9588 patients, 72% underwent CEA for asymp-
tomatic stenosis. Among asymptomatic patients, those with
high comorbidity had over twice the risk of death or stroke
compared to those without high comorbidity (7% vs 3%).
The high rate of CEA among elderly asymptomatic pa-
tients, particularly those with high comorbidities, were
associated with an adverse risk/benefit ratio in practice.
In this study, the proportion of asymptomatic patients
undergoing carotid revascularization is higher than ex-
pected. However, this observation is reported in other
studies evaluating carotid revascularization at national
level.6 The method of ascertaining symptomatic status
based on ICD-9-CM codes may lead to underestimation of
symptomatic patients. To minimize these inaccuracies, all
secondary diagnoses (up to 15) of TIA or stroke were
included as a means of further identifying the symptomatic
patients. However, we are not able to comment upon the
exact magnitude of this misclassification. It is unlikely that
such misclassification affected our primary hypothesis test-
ing because the trends across age groups were seen in both
asymptomatic and symptomatic patients. However, the
implications of such age-related increase in stroke and
cardiac complications may be more pronounced in asymp-
tomatic patients. There is lack of consensus on the optimal
management of such patients and it has been suggested that
up to 94% of carotid interventions among asymptomatic
patients may not have benefit for the patient. It is a matter
of great debate offering carotid revascularization, either
CEA or CAS, to elderly asymptomatic patients is of more
therapeutic value than adequate risk factor management
and antiplatelet treatment. Such concerns are based on the
small magnitude of benefit which can easily be offset by
small increase in rates of stroke or cardiac complications.
The recently published guidelines emphasize that the
selection of asymptomatic patients for carotid revascular-
ization should be guided by an assessment of comorbid
conditions, life expectancy, and other individual factors,
and should include a thorough discussion of the risks and
benefits of the procedure with an understanding of pa-
tient preferences.1
The observations of outcome variables in different age
strata demonstrate that the risk of stroke gradually increases
with age in patients undergoing CAS in a manner similar to
cardiac complications in patients undergoingCEA. Surpris-
ingly, the mortality rate after CAS was highest in younger
patients (less than 50 years old), however, this could be due
to the low sample size (only 3% of total sample).
Even though the NIS dataset is not ideal for comparing
CEA and CAS due to data limitations, we observed that the
CEA procedure was better with a lower risk of composite
end point in both age groups and a lower risk of in-hospital
mortality in patients 70 years undergoing CEA as well as
a lower rate of postoperative stroke in patients undergoing
CEA in patients70 years. This is consistent with previous
observations as demonstrated in the NIS dataset analysis of
years 2005 to 20076 where significantly higher overall ratesf postoperative stroke and in-hospital mortality were ob-
erved in patients undergoing CAS compared to CEA.
The limitations of studies based on administrative da-
asets such as the NIS have been described previously.4
ata are lacking on the anatomic factors, including severity
f carotid artery stenosis, vessel tortuosity, and vascular
alcifications, which are considered high-risk features for
AS.20 The design of the data acquisition and analysis does
ot allow ascertainment of events after discharge. We ac-
nowledge that such a methodology will underestimate the
ate of events after CAS and CAS. In this study, the per-
entage of asymptomatic patients is higher than expected,
owever, this observation is consistent with other studies
valuating carotid revascularization at the national level.4
he method of ascertaining symptomatic status based on
CD-9-CM codes may lead to underestimation of symp-
omatic patients. To minimize these inaccuracies, all sec-
ndary diagnoses (up to 15) of TIA or stroke were included
ith the intent to further identify the symptomatic patients.
ur outcome measures are reported at the time of dis-
harge, which is suboptimal compared to a 30-day or 1-year
utcome usually provided by other trials. Therefore, we
ay be underestimating the rates of complications. The
ortality rate in our analysis is high compared to reported
ates in the trials. Due to the limitation of the data, we
annot determine if the observed mortality and morbid-
ty events were directly related to the procedure itself or
consequence of pre-existing comorbidity. We used
ultivariate analysis to mitigate the effect of pre-existing
omorbidities.
ONCLUSION
Most CAS and CEA procedures are performed in pa-
ients aged 70 years in contemporary practice and higher
ates of postoperative complications are observed among
hese patients regardless of the procedure choice. Age alone
ay not be an important factor to decide the type of
evascularization procedure in patients with carotid disease.
dditional studies are warranted to study the importance of
ge in carotid revascularization procedures in patients with
arotid disease, whether it is symptomatic or asymptomatic.
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